The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Sangamo Therapeutics Inc

Nasdaq: SGMO
Last

(U.S.) $15.10

Today's change0.00 0.00%
Updated November 21 4:00 PM EST. Delayed by at least 15 minutes.
 

Sangamo Therapeutics Inc

Nasdaq: SGMO
Last

(U.S.) $15.10

Today's change0.00 0.00%
Updated November 21 4:00 PM EST. Delayed by at least 15 minutes.

Sangamo Therapeutics Inc down slightly

Sangamo Therapeutics Inc closed down just (U.S.)$0.00 Tuesday to (U.S.)$15.10. Over the last five days, shares have gained 17.05% and 395.08% year to date. Shares have outperformed the S&P 500 by 268.94% during the last year.

Key company metrics

  • Open(U.S.) $14.85
  • Previous close(U.S.) $15.10
  • High(U.S.) $15.50
  • Low(U.S.) $14.75
  • Bid / Ask(U.S.) $12.50 / (U.S.) $15.55
  • YTD % change+395.08%
  • Volume1,148,624
  • Average volume (10-day)1,572,064
  • Average volume (1-month)1,397,485
  • Average volume (3-month)1,556,384
  • 52-week range(U.S.) $2.65 to (U.S.) $17.06
  • Beta3.05
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.69
Updated November 21 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue12839
Total other revenue--------
Total revenue12839
Gross profit--------
Total cost of revenue--------
Total operating expense25212019
Selling / general / administrative6675
Research & development18151314
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-13-13-17-10
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-12-12-17-10
Income after tax-12-12-17-10
Income tax, total00--0
Net income-12-12-17-10
Total adjustments to net income--------
Net income before extra. items-12-12-17-10
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-12-12-17-10
Inc. avail. to common incl. extra. items-12-12-17-10
Diluted net income-12-12-17-10
Dilution adjustment--------
Diluted weighted average shares84737171
Diluted EPS excluding extraordinary itemsvalue per share-0.15-0.17-0.23-0.14
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.15-0.17-0.23-0.14